Correction of metabolic abnormalities in a rodent model of obesity, metabolic syndrome, and type 2 diabetes mellitus by inhibitors of hepatic protein kinase C–ι
Mini P. Sajan(United States Department of Veterans Affairs), Robert V. Farese(University of South Florida), Michael Leitges(Memorial University of Newfoundland), Alan P. Fields(Mayo Clinic in Florida), C. Ronald Kahn(Joslin Diabetes Center), Stephen Mastorides(James A. Haley Veterans' Hospital), Mildred Acevedo‐Duncan(University of South Florida), Ursula Braun(Medizinische Hochschule Hannover), Sonali Nimal(University of South Florida)
Cited by 34
Related Papers
Suppression of Oxidative Stress by β-Hydroxybutyrate, an Endogenous Histone Deacetylase Inhibitor
|Science|2012|1.7k
Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: Developmental culling and cancer
|Cancer Cell|2005|535
FoxO1 Regulates Multiple Metabolic Pathways in the Liver
|Journal of Biological Chemistry|2006|514
Bidirectional modulation of insulin action by amino acids.
|Journal of Clinical Investigation|1998|493